{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-018857","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2022-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.300830+00:00","generated_at":"2026-06-23T07:27:41.596398+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Corbus appoints Anne Altmeyer, Ph.D. to Board of Directors","bullets":["Dr. Altmeyer appointed to the Board effective September 20, 2022, until next annual meeting.","She receives initial option to purchase 159,200 shares of common stock and $40,000 annual cash retainer.","Altmeyer is President & CEO of TigaTx, former CBO at Sigilon Therapeutics and Adicet Bio, and held roles at Novartis and Baxalta.","Appointment brings oncology R&D and corporate development expertise to Corbus pipeline expansion.","Standard indemnification agreement executed; no reportable transactions under Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-018857","json":"https://secwatch.observer/filing/0000950170-22-018857.json","markdown":"https://secwatch.observer/filing/0000950170-22-018857.md","text":"https://secwatch.observer/filing/0000950170-22-018857.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017022018857/0000950170-22-018857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017022018857/crbp-20220920.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T07:27:41.596398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e786d9ec5","claim":"Anne Altmeyer was appointed as Director at Corbus Pharmaceuticals Holdings, Inc..","evidence_excerpt":"appointed Anne Altmeyer, Ph.D., MBA, MPH, age 58, to serve as a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017022018857/0000950170-22-018857-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}